In this segment of Gaia News: For the millions of Americans suffering from Post-Traumatic Stress Disorder there may finally be a solution. The first of its kind late-stage clinical trial of the psychedelic drug MDMA has shown great promise in treating the debilitating condition, making FDA approval likely in the next few years. Given the remarkable success of the drug, in combination with psychotherapy, to treat PTSD, many researchers now feel that it is effectively a cure. FDA approval would rightly earn MDMA its place as the leader of the psychedelic revolution in mental health.
Featuring: Dr. Gul Dolen, Scott Ostrom, Marcela Ot'alora G.
Audio Languages: English